tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ZYME Stock Latest News

Zymeworks Reshapes Board and Executive Team to Support Next Phase of Growth
Company AnnouncementsZymeworks Reshapes Board and Executive Team to Support Next Phase of Growth
7d ago
ZYME
Zymeworks announces executive changes
PremiumThe Fly
Zymeworks announces executive changes
7d ago
ZYME
Zymeworks outlines priorities, outlook for 2026
PremiumThe Fly
Zymeworks outlines priorities, outlook for 2026
7d ago
ZYME
Zymeworks Sets 2026 Strategy on Zanidatamab Momentum, ADC Pipeline and Cash-Fueled Growth
PremiumCompany Announcements
Zymeworks Sets 2026 Strategy on Zanidatamab Momentum, ADC Pipeline and Cash-Fueled Growth
7d ago
ZYME
Zymeworks (ZYME): Zanidatamab’s Strong Phase 3 HERIZON-GEA Data, Global Milestones, and Royalty Model Support Buy Rating
PremiumRatings
Zymeworks (ZYME): Zanidatamab’s Strong Phase 3 HERIZON-GEA Data, Global Milestones, and Royalty Model Support Buy Rating
12d ago
ZYME
Zymeworks’ Ziihera Sets New Survival Benchmark in First-Line HER2-Positive Gastric Cancer Trial
PremiumCompany AnnouncementsZymeworks’ Ziihera Sets New Survival Benchmark in First-Line HER2-Positive Gastric Cancer Trial
12d ago
ZYME
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint of PFS
Premium
The Fly
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint of PFS
12d ago
ONC
JAZZ
Zymeworks touts ‘unprecedented’ results from HERIZON-GEA-01 trial
Premium
The Fly
Zymeworks touts ‘unprecedented’ results from HERIZON-GEA-01 trial
12d ago
ONC
JAZZ
Jazz reports efficacy, safety results from Phase 3 HERIZON-GEA-01 trial
PremiumThe Fly
Jazz reports efficacy, safety results from Phase 3 HERIZON-GEA-01 trial
12d ago
ONC
JAZZ
Zymeworks Shareholders Back Directors, Executive Pay and Auditor
PremiumCompany Announcements
Zymeworks Shareholders Back Directors, Executive Pay and Auditor
19d ago
8K
ZYME
Zymeworks initiated with a Buy at Truist
PremiumThe Fly
Zymeworks initiated with a Buy at Truist
1M ago
ZYME
Zymeworks upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe Fly
Zymeworks upgraded to Overweight from Equal Weight at Wells Fargo
1M ago
ZYME
Oracle initiated, Uber upgraded: Wall Street’s top analyst calls
PremiumThe FlyOracle initiated, Uber upgraded: Wall Street’s top analyst calls
2M ago
W
WEN
Zymeworks initiated with an Outperform at Citizens JMP
Premium
The Fly
Zymeworks initiated with an Outperform at Citizens JMP
2M ago
ZYME
Zymeworks to Showcase Innovative Biotherapeutics at Upcoming Conferences
Premium
Company Announcements
Zymeworks to Showcase Innovative Biotherapeutics at Upcoming Conferences
2M ago
ZYME
Zymeworks to Engage in Key Investor Conferences
PremiumCompany Announcements
Zymeworks to Engage in Key Investor Conferences
2M ago
ZYME
3 Best Stocks to Buy Now, According to Top Analysts, 11/24/2025
PremiumMarket News
3 Best Stocks to Buy Now, According to Top Analysts, 11/24/2025
2M ago
DDOG
HIVE
Zymeworks price target raised to $40 from $30 at B. Riley
PremiumThe Fly
Zymeworks price target raised to $40 from $30 at B. Riley
2M ago
ZYME
Zymeworks price target raised to $40 from $37 at Leerink
PremiumThe Fly
Zymeworks price target raised to $40 from $37 at Leerink
2M ago
ZYME
Zymeworks price target raised to $25 from $17 at Wells Fargo
PremiumThe FlyZymeworks price target raised to $25 from $17 at Wells Fargo
2M ago
ZYME
Zymeworks price target raised to $40 from $30 at Stifel
Premium
The Fly
Zymeworks price target raised to $40 from $30 at Stifel
2M ago
JAZZ
ZYME
Zymeworks’ Promising Phase 3 Results Drive Buy Rating for HER2-Positive Cancer Treatment
Premium
Ratings
Zymeworks’ Promising Phase 3 Results Drive Buy Rating for HER2-Positive Cancer Treatment
2M ago
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >